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Background: Increasing international travel and migration is producing changes in trends in infectious diseases,
especially in children from many European cities. The objective of this study was to describe the epidemiology and
determine the trends of imported malaria in patients under 20 years old in the city of Barcelona, Spain, during an
18-year period.
Methods: The study included malaria cases that were laboratory confirmed and reported to the malaria register at
the Public Health Agency of Barcelona from 1990 to 2008, residing in Barcelona and less than 20 years old. Patients
were classified as natives (born in Spain) or immigrants. Differences in the distribution of demographic, clinical
characteristics, and incidence per 100,000 person-year evolution were analysed. Natives and immigrants were
compared by logistic regression by calculating the odds ratio (OR) with a 95% confidence interval (CI) and Chi-
square for a linear trend (p < 0.05).
Results: Of the total 174 cases, 143 (82.1%) were immigrants, 100 (57.5%) were female, 121 (69.5%) Plasmodium
falciparum, and 108 (62.1%) were visiting friends and relatives (VFR) as the reason for travel. Among the immigrants,
99 (67.8%) were from Equatorial Guinea. Immigrant cases more frequently travelled to Africa than natives (p =
0.02). The factors associated with imported malaria among immigrant residents was travelling for VFR (OR: 6.2 CI
1.9-20.2) and age 15-19 (OR: 3.7 CI 1-13.3). The incidence increased from 1990 to 1999 (p < 0.001) and decreased
from 2000 to 2008 (p = 0.01), although the global linear trend was not statistically significant (p = 0.41). The fatality
rate was 0.5%.
Conclusions: The majority of cases of malaria in population less than 20 years in Barcelona were immigrants,
travelling to Africa for VFR and Plasmodium falciparum was most frequently detected. The trend analysis of the
entire study period did not show a statistically significant decline. It is recommended to be aware of malaria,
especially among children of immigrants who travel to their parent’s home country for VFR. Better access to pre
travel advice should be provided.
Background
The study of imported malaria has become of more
interest in recent years than ever in before. The concern
within the scientific community reflects a problem that
is secondary to increasing international travel to
endemic regions and recent immigration from low-
income countries [1,2]. Identify and define this problem
in non-endemic countries, has allowed to identify vul-
nerable populations in various settings [3-16]. Malaria is
one of the most important infectious diseases that affect
children after an international travel [13]. Infection by
Plasmodium falciparum and immigration from sub-
Saharan Africa are characteristics of the majority of
imported malaria cases in Spain [7-9], as well as in
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(EUA) [13-17].
Imported malaria characteristics and incidence evolu-
tion for vulnerable populations such as children are still
not well understood in spite of a disproportionally high
number of cases [7,11]. For example, 15-20% of the total
reported cases of imported malaria correspond to chil-
dren and young adults [7,12,18]. This population
deserves special attention because it may be producing a
significant increase in morbidity and mortality of a pre-
ventable disease [13].
Affected children in European countries and cities are
typically resident immigrants of non-endemic countries
who travel to their country of birth or their parent’s
birthplace to visit friends and relatives (VFR) [13,19-21].
Recent studies have also shown poor adherence to che-
moprophylaxis (CP) and a higher probability to be hos-
pitalized among this population [7,9,13,20,22].
Population-based studies, which would show incidence
rate evolution and define the problem, are scarce. The
objective of this study was to describe the epidemiologi-
cal characteristics of imported malaria cases among chil-
dren and young adults under 20 years of age and to
examine the incidence evolution in a European city dur-
ing a long period of time. Identification of the patient
profile will allow for a connection between specialized
healthcare centres and public health measures to pre-
vent imported malaria in children and young adults.
Methods
Population and study period
A population-based observational study design was
implemented to examine confirmed imported malaria
cases in children less than 20 years of age, residents of
the city of Barcelona, and reported to the malaria regis-
try of the Public Health Agency of Barcelona (Spain)
Epidemiology Service between January 1, 1990 and
December 31, 2008. Relapses (cases with new symptoms
and/or parasitaemia who have not travelled again) were
excluded. Reporting imported malaria cases to public
health is mandatory in Spain. In Barcelona a laboratory
surveillance system exists but cases are reported by the
clinicians. Epidemiological surveys are completed by
public health nurses.
Definitions
Imported malaria was defined as acquired in an ende-
mic area and compliant with diagnostic criteria of
microscopic observation of parasites in a thick periph-
eral blood smear or genomic detection by amplification
techniques in a non-endemic country [23]. An immi-
grant was defined as born in an endemic area and resi-
dent of the city of Barcelona. VFR immigrant was
defined as having travelled to their country of origin to
visit friends and relatives, and a recently arrived immi-
grant was defined as having arrived in Barcelona with
malaria before residency. Immigrant children born in
Barcelona were considered natives [24].
Laboratory
Cases and species were confirmed by microscopic obser-
vation of parasites in a thick and thin blood film and by
PCR as previously described [7].
Variables
The following variables from the epidemiology survey
for each case were systematically reviewed: socio-demo-
graphic characteristics (sex, age, country of birth, place
of residence), epidemiological characteristics (reporting
healthcare centre, hospitalization, endemic geographical
region visited in the 30 days previous to symptom
onset), reason for travel (VFR, work, volunteer or
recently arrived), diagnostic variables (species and tech-
nique), chemoprophylaxis, treatment, and date of symp-
tom onset, diagnosis, hospitalization admittance and
discharge. Laboratory registries and clinical histories
were reviewed at the tropical disease reference centre of
Barcelona for additional information.
Statistical analysis
A descriptive analysis of the variables was performed.
Quantitative variables were described using medians and
interquartile ranges (IR) according to their no normal
distribution. The x
2 test was used to compare qualitative
variables. ANOVA and corresponding non-parametric
tests were used to compare quantitative variables. Inci-
dence rates were calculated per 100,000 person-years
according to the total population average for a five-year
period (data was obtained from the city census) [24].
Recently arrived immigrants were excluded from inci-
dence rate calculations. Incidence evolution during the
study period was analysed using an x
2 and adjusted lin-
ear trend test.
Differences between immigrant and native cases on
bivariate and multivariate levels were compared using a
logistic regression model and odds ratio (OR) with a
95% confidence interval (CI). Variables from the bivari-
ate model with a p-value less than 0.05 and those of epi-
demiological interest were included in the multivariate
model. Fatality rates were calculated according to the
total number of deaths and total cases per 100. Statisti-
cal package SPSS 18 and Epi Info 6 were used for the
statistical analysis.
Results
The 174 cases reported during the study period were
included. The median age was 9.6 years (IR: 5-15 years),
one hundred cases (57.5%) were female and 143 (82.1%)
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Africa (146 cases, 83.9%), of which 53.4% travelled to
Equatorial Guinea (EG) and 8% to Cameron. Of the 125
cases who were prescribed chemoprophylaxis, almost all
did not take it correctly (121 cases, 96.8%). The most
common reason for travel was VFR (108 cases, 62.1%)
and the most commonly detected species was P. falci-
parum (121 cases, 69.5%).
Imported malaria incidence increased from 1.65 cases
per 100,000 persons under 20 years old in 1990 to four
cases per 100,000 in 1997, at which point it declined to
reach 1.6 cases per 100,000 in 2008. The linear trend
analysis showed a significant increase from 1990 to 2000
(p < 0.001) and a decrease from 2001 to 2008 (p =
0.01). However, analysis of the entire study period did
not show a statistically significant decline (p = 0.41)
(Figure 1).
Table 1 summarizes the epidemiological characteris-
tics of native and immigrant cases.
Immigrant cases more frequently visited Africa com-
pared to their native counterparts (0.02). Excluding
recently arriving immigrants with malaria, no difference
in sex, district of residence, country of travel or detected
species between resident immigrants and natives were
found. Similarly, no difference was seen in hospitaliza-
tion or chemoprophylaxis completion between the two
groups (Table 2). The factors associated with imported
malaria among young resident immigrants in Barcelona
were age between 15 and 19 years (OR: 3.7, CI 1-13.3)
and VFR (OR 6.4, CI 2-19.9).
Among the 108 cases with VFR as the reason for tra-
vel, 31 cases (28.7%) had a previous episode of malaria
in their life, 97.2% did not correctly complete chemo-
prophylaxis and 27 cases (11.1%) required hospitaliza-
tion. Six cases (6.5%) were hospitalized between 1990
and 1999, and 21 cases (26.3%) were hospitalized
between 2000 and 2008 (p < 0.001). During the 18-year
study period, one death due to malaria was reported
(fatality rate of 0.54%).
Discussion
Imported malaria in young adults of Barcelona predomi-
nantly affected immigrants over five years of age who
travelled to Africa (most frequently EG) to visit friends
and relatives, did not complete chemoprophylaxis, were
infected with P. falciparum and were treated without
need of hospitalization. Age 15-19 years and VFR were
associated factors to resident immigrants compared to
natives. This study also found a decline in imported
malaria incidence in recent years, which was not statisti-
cally significant.
As described in adult populations of similar settings in
Spain and other European countries [8,10,13,15,
16,22-25], the majority of children affected by imported
malaria in this study were African immigrants or chil-
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Figure 1 Evolution of imported malaria rates in cases under 20 years of age. Barcelona 1990-2008.
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GeoSentinel Surveillance Network found that 69% of
children needed hospitalization. Plasmodium falciparum
accounted for 78% of all malaria cases, 95% of which
were acquired in sub-Saharan Africa [13]. A high num-
ber of malaria cases were found in EG immigrants and
their children, which has been analysed in previous stu-
dies performed in Barcelona and other Spanish cities
[18,25,28]. This high number of cases among Guinean
population and the existence of two Tropical Medicine
Units in the city, could explain the low percent of hospi-
talizations in Barcelona.
Many immigrants that are established residents in
Spain visit their home country [29] with their children,
who have rarely or never been exposed to malaria and
thus possess little or null natural semi-immunity. These
travellers are not accustomed to seek pre-travel advice
or take chemoprophylaxis, although they travel to rural
areas for longer periods of time [4,7,19]. A big concern
is what Hagmann et al described in a recent study; VFR
children were less likely than adults to receive pre travel
medical advice [13]. Like the rest of the travellers, resi-
dent immigrants and children who travel should be edu-
cated about the various preventative measures, such as
barriers, impregnated nets and chemoprophylaxis com-
pletion for travel to endemic regions. Innovative meth-
ods to improve access to pre-travel services for VFR
should be implemented [13,14].
The association between imported malaria and VFR in
patients under 20 years old has been reported in various
European cities and countries [13,18,30] and was thor-
oughly described in a recent study about childhood
malaria in England and Ireland [12]. The characteristics
of imported malaria cases found in our study, such as
VFR travel reason, P. falciparum infection, and incom-
plete chemoprophylaxis use, are similar to those
described in other cosmopolitan cities of the world
[3,21,22]. Plasmodium falciparum is the most frequently
identified species in children [26,30,31] not only in Bar-
celona, but also in the rest of Spain [8,11,32-36], other
European countries [13,15,17,26] and in the USA
[6,37,38].
The infrequent use of chemoprophylaxis is a concern
on a global scale. Although anti-malarial drug resis-
tances are emerging in endemic countries, chemopro-
phylaxis is still effective and selection of a good
regimen, along with barrier and repellent precautions, is
key to decreasing the risk of acquiring malaria [39]. The
rate of correct chemoprophylaxis completion among
cases in this study population is similar to that found in
previous studies, which ranges from 3-15% [19,31,38].
These results demonstrate the severity of this problem.
However, further evaluation is needed as we do not
know how many people in the same age group in the
general population travelled and performed chemopro-
phylaxis correctly. One explanation about the low che-
moprophylaxis completion could be the false cultural
idea that people born in endemic regions and their
families are protected against malaria [22], underesti-
mating the importance of disease and its potential fatal-
ity. It is also important to note that 28.7% of the
resident immigrants travelling for VFR who did not
complete chemoprophylaxis had previously suffered
from malaria. Nonetheless, it would be important in the
future differentiate if the previous malaria episode was
in all the patients life or as a VFR. However, this per-
cent is similar to the 26% found in a study from Eng-
land in 2007 [12], and exposes an important missed
opportunity for patient education about disease
Table 1 Characteristics of 174 reported malaria cases in










Male 60 (42.0) 14 (45.2) 74 (42.5) 0.56
Female 83 (58.0) 17 (54.8) 100 (57.5)
Age (years)
< 5 40 (28.0) 13 (41.9) 53 (30.5) 0.65
6 to 14 59 (41.3) 12 (38.7) 71 (40.8) 0.24
15 to 19 44 (30.8) 6 (19.4) 50 (28.7)
District of residence
Other 119 (83.2) 27 (87.1) 146 (83.9) 0.19
Inner City 24 (16.8) 4 (12.9) 28 (16.1)
Continent of travel
Africa 125 (87.4) 21 (67.7) 146 (83.9) 0.02
Asia 11 (7.7) 4 (12.9) 15 (8.6)
America 3 (2.1) - 3 (1.7)
Unknown 4 (2.8) 6 (19.4) 10 (5.7)
Reason for travel (VFR)
No 55 (38.5) 11 (35.5) 66 (37.9) 0.88
Yes 88 (61.5) 20 (64.5) 108 (62.1)
Species detected
P. falciparum 103 (72) 18 (58.1) 121 (69.5) 0.64
P. vivax 18 (12.6) 7 (22.6) 25 (14.4)
P. ovale 7 (4.9) 3 (9.7) 10 (5.7)
P. malariae 7 (4.9) 1 (3.2) 8 (4.6)
Mixed 4 (2.8) 1 (3.2) 5 (2.9)
Plasmodium spp 4 (2.8) 1 (3.2) 5 (2.9)
Chemoprophylaxis
Yes 3 (2.1) 1 (3.2) 4 (2.3) 0.53
No 140 (97.9) 30 (96.8) 170 (97.7)
Hospitalization
Yes 22 (15.4) 5 (16.1) 27 (15.5) 0.7
No 121(84.6) 26 (83.9) 147 (84.5)
VFR: visiting friends and relatives.
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and 90% adherence, 105 of the 129 cases of malaria in
resident immigrants could have been avoided.
The increase in incidence from 1990 to 1999 can be
attributed to the high in international travel to endemic
regions and infrequent use of chemoprophylaxis. The
later decrease in incidence between 2000 and 2008
could be due to decreased incidence in endemic coun-
tries by the use of artemisinins and mosquito control
programmes. Better travel advice, higher quality of travel
health information in hospitals and primary care facil-
ities and the correct use of chemoprophylaxis could also
had a role in the decrease of incidence. There are many
other factors that could also affect the incidence calcula-
tions such as migration flow, the census development
and case reporting. Nonetheless, according to the linear
trend analysis, the decline over the entire study period
was not significant. Malaria incidence among children
had not been previously described but one study from
The Netherlands reported decreasing incidence among
adults [10]. The incidence of two cases per 100,000
reported in this study is slightly inferior to that reported
in 2007 in the UK (2.8/100,000 per year) and Ireland
(4.6/100,000 per year) in children less than 16 years of
a g e[ 1 2 ] .T h i sd i f f e r e n c ec o u l db ed u et h eh i g ha m o u n t
of immigration from endemic countries to the UK in
comparison to Catalonia or Spain. Although arguably
low, this incidence is not satisfactory for a preventable
disease.
Studies that have assessed imported malaria among
children have showed the important aspects of the clini-
cal epidemiological patterns in various non-endemic
countries [19,40]. One strength of this study is the large
study population. It is the first population-based study








Crude OR (95%CI) Adjusted OR (95%CI) P value
Sex
Female 54 (56.3) 14 (48.3) 68 (54.4) 1 1 0.41
Male 42 (43.8) 15 (51.7) 57 (45.6) 0.7 (0.3-1.7) 0.7 (0.3-1.7)
Age (years)
< 5 27 (27.8) 12 (42.9) 39 (31.2) 1 1 0.044
6 to 14 41 (42.3) 11 (39.3) 52 (41.6) 1,4 (0.6-3.8) 1.9 (0.7-5.3)
15 to 19 29 (29.9) 5 (17.8) 34 (27.2) 2,6 (0.8-8.3) 3.7 (1-13.3)
District of residence
Other 79 (81.4) 24 (85.7) 103 (82.4) 1
Inner city 18 (18.6) 4 (14.3) 22 (17.6) 1.4 (0.5-4.7)
Continent of travel
Asia 9 (9.4) 4 (16.7) 13 (10.8) 1
America 3 (3.1) 0 (0) 3 (2.5) 1
Africa 84 (87.5) 20 (83.3) 104 (86.3) 2,4 (0.9-6.6)
Reason of travel (VFR)
No 9 (9.3) 8 (28.6) 17 (13.6) 1 1 0.003
Yes 88 (90.7) 20 (71.4) 108 (86.4) 5 (1.7-14.4) 6.4 (2-19.9)
Species detected
P. falciparum 68 (70.1) 16 (57.1) 84 (67.2) 1.6 (0.7-3.9)
P. vivax 14 (14.4) 6 (21.4) 20 (16) 1
P. ovale 4 (4.1) 3 (10.7) 7 (5.6)
P. malariae 3 (3.1) 1 (3.6) 4 (3.2)
Mixed 4 (4.1) 1 (3.6) 5 (4)
Plasmodium spp 4 (4.1) 1 (3.6) 5 (4)
Chemoprophylaxis
No 93 (69.9) 28 (96.6) 121 (96.8) 1
Yes 3 (3.1) 1 (3.4) 14 (3.2) 0.9 (0.09-9)
Hospitalization
No 87 (90.6) 24 (82.8) 111 (88.8) 1
Yes 9 (9.4) 5 (17.2) 14 (11.2) 0.5 (0.2-1.6)
* 49 recently arrived immigrants were excluded.
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over the last 18 years. The limitations of the study are
the lack of clinical data information, reasons for hospita-
lization, as well as data about parents’ country of birth.
Immunology studies and patterns of travel among immi-
grants and the time spent as residents of a non-endemic
country would also help us associate the disease with a
level of semi-immunity in the future [41,42].
The fatality rate was similar to previous studies per-
formed in industrialized cities, except in Italy, Japan,
Great Britain and Sweden, in which no deaths were
reported [12,26]. The vulnerability of the patients must
not be forgotten, even though the lethality rate repre-
sents only one death. This patient was the son of immi-
grant parents from an endemic region, less than five
years of age, who had travelled for VFR to a region of
sub-Saharan Africa. He had never had malaria and did
not complete chemoprophylaxis. Diagnostic delays of
malaria are associated with higher rates of hospitaliza-
tion and mortality, thus malaria should be considered
for any child with a history of recent travel to an ende-
mic country. This is especially important because
malaria symptoms are non-specific and a diagnostic
delay can be fatal [12,13,43].
Challenges for health systems in developed countries
in the control of imported malaria include the improve-
ment of information dissemination of preventative mea-
sures, the correct use of chemoprophylaxis when
necessary and rapid diagnosis of clinical cases [43-45].
To reduce the risk of a diagnostic delay, protocols for
primary care, emergency care and paediatric facilities
should specify malaria as a possibility for immigrant
patients and those who travel to an endemic region. Pri-
mary care teams working in areas of high immigration
should also implement community activities to improve
information availability and awareness. Furthermore, to
promote their use, chemoprophylaxis recommendations
should be available in most languages. Medicine is a
dynamic and bio-psycho-social science in which many
groups are involved and it is, therefore, necessary to
quickly adapt to the needs of the population at any
moment.
Conclusions
The majority of cases of malaria in population less
than 20 years in Barcelona were immigrants, travelling
to Africa to VFR and P. falciparum was the most fre-
quently detected species. It is recommended to be
aware of infectious diseases, such as malaria, especially
in children and young adults who travel to their par-
ent’s home country to visit friends and relatives.
Furthermore, worldwide prevention programmes tar-
geting these vulnerable populations should be
enhanced by providing better access to travel advice to
prevent the disease.
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